Skip to main content

Prevalence and phenotype of eating disorders in assisted reproduction: a systematic review

Abstract

Background

Eating disorders (EDs) are common conditions that mainly affect women of reproductive age and have a major impact on fertility. Our systematic review focuses on the prevalence of EDs in patients in the process of assisted reproductive technique (ART) and describes the phenotypes of EDs identified.

Methods

Our systematic review is based on the PRISMA criteria. Articles were collected using the Medline/Pubmed, Web Of Science and Cochrane databases. The articles chosen had to mention the prevalence of ED in infertile patients undergoing ART and be cohort or case–control studies assessing the prevalence of ED during fertility treatment.

Main findings

Fifteen articles were included in this review. The prevalence of active ED varied between 0.13 and 44% depending on the types considered in each study. The main phenotypes described were EDNOS (eating disorder not otherwise specified) and binge eating disorders (BED) occurring in women with a normal body mass index (BMI) and a history of ED. Mainly subthreshold forms with cognitive distortions were described.

Conclusion

This review highlights a 6 times higher prevalence of EDs in infertile patients undergoing fertility treatment compared to regular pregnant women. However, diagnosing these conditions is complex. As a result, it is essential that professionals in contact with this population are alert to symptoms consistent with these conditions in order to refer them to specialized psychiatric care.

Résumé

Introduction

les troubles des conduites alimentaires (TCA) sont des pathologies fréquentes affectant principalement les femmes en âge de procréer avec un impact majeur sur la fertilité. Notre revue de la littérature s’intéresse à la prévalence du trouble chez les sujets inscrits dans un processus d’assistance médicale à la procréation (AMP) et décrit les phénotypes des TCA repérés.

Méthode

notre revue de la littérature se base sur les critères PRISMA. Les articles ont été collectés en utilisant les bases de données Medline/Pubmed, Web Of Science et Cochrane. Les articles sélectionnés devaient faire état de la prévalence des TCA chez les sujets infertiles recourant à une AMP, être des études de cohorte ou cas-témoins évaluant la prévalence des TCA au cours d’une AMP.

Résultats

quinze articles ont été inclus dans cette revue. Les prévalences de TCA actifs variaient entre 0,13 et 44% en fonction des formes considérées. Les principaux phénotypes décrits étaient les formes non spécifiques (EDNOS) et hyperphagiques (BED) survenant chez des femmes avec un indice de masse corporel (IMC) normal et présentant des antécédents de TCA. Il était décrit des formes subsyndromiques prédominées par des distorsions cognitives.

Conclusion

cette revue met en évidence une prévalence de TCA supérieure chez les sujets infertiles recourant à une AMP par rapport aux femmes enceintes en population générales. Leur diagnostic est cependant complexe. Il est donc capital que les professionnels au contact de cette population soient vigilants aux symptômes évocateurs afin d’orienter vers une prise en charge spécialisée.

Plain English Summary

Eating disorders are frequent pathologies that primarily affect women of childbearing age. Numerous articles reveal an increased risk for the mother and the child in case of an active disorder during pregnancy.

We conducted a systematic review to determine the prevalence and phenotypes of eating disorders in infertile subjects undergoing fertility treatment.

The results of the fifteen articles included show a prevalence six times higher than in pregnant women in the general population. Subjects with eating disorders have normal body mass indexes. The active forms are mainly characterized by episodes of binge eating disorders or other unspecified forms. Studies also describe incomplete forms characterized by the presence of dysfunctional thoughts around shape and weight without associated compensatory behavior.

Professionals working in the field of reproductive medicine and providing fertility treatment have a major role to play in identifying and referring these subjects at risk to specialized care.

Peer Review reports

Background

Eating disorders (EDs) are severe conditions which mainly affect women [1]. Although they have been discussed for a long time, it is only since the 80s that they have been considered as a psychiatric pathology. Since then, the definition of these disorders has continued to evolve. The DSM-5 categorizes EDs into seven types, defining them as follows: “feeding and eating disorders are characterized by a persistent disturbance of eating or eating-related behavior that results in the altered consumption or absorption of food and that significantly impairs physical health or psychosocial functioning” [2]. EDs usually appear during adolescence, or at beginning of adult life. Currently, the prevalence of lifetime EDs in women in the general population varies between 8 and 10%, with a peak incidence in women at the beginning of reproductive age, at the end of the adolescence [1].

Recent studies carried out on women suffering from EDs report difficulties to control their fertility [3, 4]. Infertility has often been described in women with current EDs [5, 6]. It may occur at different stages of the weight-loss process, and it may persist after weight recovery. The mechanisms are partially known. They mainly involve the hypothalamic-pituary-gonadal axis. Recent works on hormonal and neuroendocrine pathways involving leptin, ghrelin or the corticotropic axis, helps to explain the impact of variations in energy intake on the central nervous system [7,8,9,10].

Several studies, including Easter et al., 2011, found that women suffering from EDs were twice as likely than the general population to have received fertility treatment or assisted reproductive techniques (ART) [11,12,13]. Similarly, Bye et al., and a French cohort of midwives highlight the difficulties of identifying EDs [14, 15]. Due to the variability in clinical presentations and the difficulties in diagnosing EDs, there is a high risk of underestimating the real prevalence of this condition.

Indeed, international guidelines recommend early and multidisciplinary treatment of EDs in order to improve the maternal and fetal prognosis [5, 16]. Early identification during the fertility treatment could be of major interest for both mother and fetus. Therefore, we conducted a systematic review of the literature. Our primary outcome was to investigate the prevalence of EDs in women seeking fertility treatment. The secondary outcome of this review is to describe the phenotypes of these EDs.

Materials and methods

We performed a systematic review according to the PRISMA guidelines [17].

Between March and July 2021, a search of three databases (MEDLINE, Cochrane and Web of Science) was perform using a combination of key words such as infertility, assisted reproductive technique, feeding and eating disorders and the different type of EDs. The datasets supporting the conclusions of this article are available in the the PubMed repository, [https://pubmed.ncbi.nlm.nih.gov], the Cochrane library [https://www.cochranelibrary.com], and Web Of Science [https://www.webofscience.com]. As an example, for the PubMed search, the search term was defined as follows: (("Reproductive Techniques, Assisted"[MH]) OR (“Assisted reproductive technology” [TIAB]) OR (“ART” [TIAB]) OR ("Infertility"[MH]) OR (“infertility”[TIAB])) AND (("Feeding and Eating Disorders"[MH]) OR (“eating disord*”[TIAB]) OR ("Anorexia"[MH]) OR ("Anorex*"[TIAB]) OR ("Bulimia"[MH]) OR ("Bulimia"[TIAB]) OR ("Binge-Eating Disorder"[MH]) OR ("Binge-Eating Disorder"[TIAB])) along with a “human” search filter. No limits were applied with regards to publication date. This algorithm was adapted for each database. Gray literature was also consulted.

Selected articles followed inclusion criterias:

  • Assess in their primary or secondary objective the prevalence of EDs, or present results allowing the calculation of a prevalence of EDs during fertility treatment

  • be medical articles from quantitative cohort or case control studies

  • be published in French or English

Articles were excluded if they: did not meet the inclusion criteria; investigated the prevalence of ART in patients with EDs; studied infertile females, without providing information on whether or not they received infertility treatment; were reviews, meta-analyses, case reports, or case study; did not allow a prevalence to be calculated.

The bibliographies of the excluded articles have been analysed to ensure that no relevant references were ignored.

Articles were reviewed for eligibility through titles, then abstracts and subsequently full texts if relevant. The articles included underwent standardized critical analysis of their methodology, using the STROBE checklist. However, no references were excluded from his analysis.

Double-blind research was conducted by AC. The results were compared and discussed in order not to ignore any reference.

The results were summarized in a table. Main characteristics were then analyzed in a descriptive synthesis.

Results

Database searches revealed three hundred and twenty-one articles. The flow chart describes the selection process (Fig. 1). The second reading revealed 5 points of disagreement. One of these articles was included in our analysis. The other four references were excluded because they investigated the prevalence of ART in patients with EDs which was one of our exclusion criteria. Thus, we obtain a strong agreement between the investigators with a Kappa index of 0.76.

Fig. 1
figure 1

Flow chart

Overall, fifteen references were included. Two articles were selected by the analysis of the bibliographies. Their characteristics and results of interest are given in Table 1. The studies included were mainly anglo-saxon (N = 7) or nordic (N = 3).

Table 1 summary of the articles included in the systematic review

Prevalence

The prevalence of active EDs was found to be between 0.13 and 35.7%. This rate increased to 44% if subthreshold forms were associated to complete active forms [18,19,20,21,22,23,24,25,26,27].

Articles describing a history of EDs found a prevalence ranging from 4.1 to 92.8% [18,19,20,21,22, 24, 28]. The three studies carried out on infertile females receiving GnRH stimulation, reported elevated histories of EDs, ranging from 45.8 to 95.2% [18, 28, 29]. Barbosa et al., found that women suffering from infertility of hypothalamic origin were found to have a history of ED that was four times higher than those in the control group with another type of infertility [18].

Four articles focused on the lifetime prevalence of EDs in infertile women [8, 29,30,31]. The prevalence in those cases was found to be between 0.2 and 95.2%. Only Assens et al. found that the prevalence of lifetime EDs was lower in infertile females undergoing fertility treatment than in the general population (0.63% vs 0.73%, p = 0.025) [31].

Phenotypes

Body mass index

Ten studies looked at body mass index (BMI) [8, 18,19,20,21, 24, 26, 28,29,30]. Nine of these found normal BMI values (18.5–25 kg/m2) in women suffering from EDs. BMI values were not statistically different to those of women not suffering from an ED, nor from those in the general population. The study carried out by Cousin et al. noted that although women with EDs had normal BMI, these were significantly lower than for those in the control group (p = 0.019) [19].

Barbosa et al. found that the BMI of infertile females was normal, except for those whose infertility was of hypothalamic origin (23.1 vs 18.1 kg/m2). The differences in BMI values between the two groups was statistically significant. Women with infertility of hypothalamic-pituitary origin also reported statistically lower BMI minima than the other types of infertility (15.7 vs 19.8 kg/m2) [29].

Sbaragli et al. in 2008, found BMI which were in the normal to high range (23.8–25 kg/m2) or even in the overweight range, for women suffering from infertility caused by polycystic ovarian syndrome (PCOS) before undergoing fertility treatment [22].

Types of EDs

The EDs studied in the articles varied depending on the standards used (DSM III to IV-TR). Studies that reported lifetime prevalence and history of EDs identified a predominance of a history of anorexia nervosa in infertile women [8, 18, 28,29,30,31]. When considering only current EDs, the most common ED was eating disorder not otherwise specified (EDNOS), including binge eating disorders (BED) [18, 22, 25, 30].

Three studies specifically focused on women suffering from functional infertility of hypothalamo-pituitary origin with hormonal stimulation with GnRH [18, 28, 29]. These studies focused on women suffering from infertility of hypothalamo-pituitary origin, either functional or genetic [18]. They found a predominance of active anorexia nervosa in these women (95.2%, or 20 out of 21 women). Barbosa et al. was the only one to use a control group, which included women with other types of infertility. The EDs identified in the control group were also of the restrictive anorexia nervosa type [29].

Sbaragli et al., found a significant association between BED, or a history of BED, and PCOS [22]. Rodino et al. found that obese women, independently of their PCOS status, had a significantly higher risk of suffering from a BED (OR 7.9, CI (3.421–18.312), p < 0.001) [24]. In another article, Rodino et al. found that there was a tendency towards food compulsions in women with ovulatory disturbances. This study also reported that infertile females were more likely to use weight-control measures such as induced vomiting and laxatives. They also had a significantly higher probability of engaging in high-intensity physical activity (OR 6.98, CI (1.39–34.90), p = 0.018) [21]. Other studies were consistent with these results [18, 19, 28, 30].

Sbaragli et al. investigated the association between BED and infertility in men. The results found no significant difference between infertile males, and the fertile control group [22].

Cognitive patterns and dysfunctional thoughts

Using the EDE-Q questionnaire, the studies showed that the infertile females’ scores were significantly higher in the ED groups than in the non-ED groups for the following factors: perfectionism; a drive for thinness; and eating, weight and shape concerns [8, 19, 21, 24, 30]. These factors were found at significantly higher rates in ovulatory infertility [21].

Eighty-one percent of infertile women, regardless of their ED status, reported a desire to lose weight before their first medical consultation. 40% percent of them reported “unrealistic” weight loss goals, which, in 7.1% of cases would lead to underweight [20].

In contrast, the studies carried out by Cousins et al. and Freizingher et al. showed that dietary restraint and concerns were either similar, or significantly lower than for women without EDs or women from the general population. These women also had lower body dissatisfaction scores [19, 30].

With regards to the desire for a child, Bruneau et al. showed that a low BMI and high body shape concern score were associated with an ambivalent desire to have a child [8].

Comorbidities and follow-up

Volgsten et al. found that 30.8% (N = 127) of infertile females had a psychiatric diagnosis, and that this number was 10.2% (N = 42) for infertile males. It also found that several psychiatric comorbities were also common in infertile subjects. 36.2% of women had two associated comorbidities, and 7.9% had three or more [26].

With regards to anxiety, Bruneau et al. found that women with an ED had a significantly higher level of anxiety than those without an ED [8]. Sbaragli et al. found that infertile females were more likely to have a history of anxiety disorders [22]. However, Cousin et al. did not find any significant differences between the two groups with regards to the anxiety trait or state [19].

With regards to depression, statistical analyses did not find any significant differences between women with and without EDs [8, 19].

Yli-Kuha et al. identified a lower number of hospitalizations for EDs when ART resulted in a pregnancy that went to full term. The number of children did not seem to affect the number of hospitalizations [27].

Before undergoing the treatment procedures, 83% of women were aware of their EDs diagnosis [31], and 57% stated that they benefited from psychiatric follow-up [18]. Volgsten et al. found that 20.7% (N = 23) of subjects suffering from a psychiatric pathology benefited from psychiatric treatment (psychotherapy and/or treatment with medications) [26]. Langley et al. found that only one-third of women accepted a dietary counselling offered to them after risk factors for ED were identified [20].

Freizinger et al. reported that 76.4% of women did not disclose their disorder to their physician [30]. Rodino et al. also found low levels of disclosure [21].

Type of infertility and art procedure

Infertile females with an ED had significantly more ovulatory or functional infertility. Resch et al. identified that incomplete forms of bulimia were also associated to anovulation [23]. Works carried out on infertility of hypothalamo-pituitary origin have reported a regular resumption of cycles after returning to a “normal” weight, or hormonal stimulation [18, 28, 29]. According to Assen et al., in-vitro fertilizations or intracytoplasmic sperm injections were significantly more frequent with ovulatory disorders. Women with EDs underwent significantly fewer treatment cycles than women without EDs (between 1 and 3 cycles, p = 0.035) [31].

Discussion

To our knowledge, this systematic review is the first one to discuss the prevalence and phenotypes of EDs in infertile females undergoing fertility treatment. There are few studies that deal specifically with the prevalence of EDs with ART (N = 9).

The studies’ findings regarding the prevalence of EDs (between 0.13 to 95.2%) were highly variable and depended on whether the focus was placed on current, past, or lifetime EDs. The difficulty in carrying out a robust comparative analysis can be explained by the differences in methodology between the studies, as well as by their respective biases. Inclusion criteria (age, gender, sexuality) and fertility treatment strategies differ according to the country. In Nordic studies, registries exclude women who underwent artificial insemination [26, 27, 31]. However, when associated with ovulation induction, this is an effective first-line treatment for functional infertility [32]. This explains the very low rate of EDs in Nordic cohorts. Similarly, the study conducted by Yli-Kuha et al. focused on hospitalizations, leading to the identification of only the most extreme clinical situations [27]. It is therefore possible to infer that the prevalence of EDs in infertile females in those countries is higher than that found in the studies.

We notice an important heterogeneity in the diagnostic criteria for EDs in the studies. This includes standards changes (ICD, DSM), evolution between the DSM-III and the DSM-IVTR and heterogeneity in tools to detect EDs. Moreover, these tools are used in the absence of validated questionnaire which can be used in the peripartum period [33]. Finally, the quality of the methodology of some of the articles is debatable. Two of the articles conform to fewer than half of the STROBE checklist’s quality criteria for observational studies [18, 20]. Apart from the two national cohort studies, the study sample sizes were small with a significant attrition rate up to 33% [23, 26, 30].

Although the values of the results which appear in our review are difficult to analyze, the orders of magnitude of the prevalence are substantially higher than those found in pregnant women. The literature states that the prevalence of current EDs in pregnant women is between 5.1 and 7.5%, i.e. up to six times less than in our population of interest [34].

With regards to the phenotype of current EDs in infertile women, they are mainly EDNOS or BED forms. These are associating episodes of binge eating and compensatory activities (sustained physical exercise) for weight-control purposes. This data agrees with studies of EDs in pregnant women [34,35,36]. Several studies in our review found subthreshold types of EDs [19, 21, 23, 30]. Subsyndromal types of EDs include body image perturbations, with some body dysmorphia, and without any associated compensatory activities [26]. In a study carried out by Fassino et al. in 2008, which excluded infertile females with a known ED, questionnaires showed some cognitive patterns in common between infertile women and women with anorexia nervosa. These characteristics included feelings of inadequacy, insecurity and fears related to maturity. Interpersonal disturbances are significantly more frequent in those experiencing functional infertility. However, they did not include altered attitudes or behavior with regards to food [37]. The presence of those cognitive patterns is significantly correlated with a higher risk of obstetrical and neonatal complications. Notably, a lower Apgar score at five minutes has been described in newborn babies born to women with subsyndromal EDs [3].

In their work, Bruneau et al. described ambivalence to desire for a child in women with high body concerns. This result needs to be substantiated by regression analyses while also considering potential confounding factors such as maternal depression. Nevertheless, this ambivalence is an important factor to consider when establishing the parent–child relationship. As a matter of fact, the existence of a maternal ED during pregnancy increases the risk of postpartum depression and can represent an obstacle to the establishment of an early bond [38]. Mothers with an ED report greater difficulties in determining their child's needs. There is a risk that women with restrictive anorexia nervosa will project their eating and body concerns into their child [36]. Newborns of mothers with an active ED during pregnancy show difficulties in maintaining their homeostasis when faced with stress factors. These children also face more difficulties in emotional regulation as they grow up. A neurodevelopmental pathway has been put forward to explain this vulnerability. The pathway incorporates hormonal, metabolic and epigenetic mechanisms linked to maternal pathological eating behaviors during the period of synaptic formation and myelination in the third trimester of pregnancy [39].

Multiple studies in our review observed that women do not disclose their history of ED to their doctor even though their symptoms may still be active. This problem can affect up to three quarters of infertile females with an ED [30]. This problem is well documented in the literature [13, 40]. In 2018, Bye et al. assessed the obstacles for diagnosing EDs in pregnant women. Firstly, there are obstacles that are an intrinsic part of the disorder such as denial or lack of desire to change [15]. In the specific case of infertility treatment, some women report not passing on information about their ED because they were unaware of the impact it could have on fertility [30]. Moreover, the fear of stigma affects the disclosure to healthcare professionals. The stigma of mental health is widely acknowledged, but it may be even greater in the case of EDs. Indeed, sufferers are incorrectly seen as being more responsible and in control of their eating behavior than the general population [41]. In tandem, health professionals appear to have little confidence in their ability to identify EDs. Furthermore, women and healthcare professionals report that there is a lack of opportunity and time in routine antenatal care to openly discuss EDs [15].

As a result, checking for EDs symptoms in infertile females seeking fertility treatment is a complex task. Healthcare professionals who carry out preconception assessments have a major role to play in the monitoring and referral of patients at risk of an ED. Including brief screening techniques for eating disorders in the assessment could be useful [21]. The use of the 5-items rapid questionnaire SCOFF (Sick, Control, One, Fat and Food) has been recommended [42]. This tool offers good sensitivity for screening for anorexia nervosa and bulimia. In contrast, it is less sensitive for screening BED and using it in overweight populations is less reliable [43].

In 2019, Paslakis et al. updated a screening algorithm based on the 2009 version by Andersen and Ryan. They recommend using the shortened 8-item version of the Eating Attitude Test (EAT-8) because of the good positive predictive value, in combination with anthropometric measurements such as weight and BMI. However, the EAT-8 only exist in a German validated version. As a result, the use of the SCOFF questionnaire remains an interesting alternative. Having carried out our review, it seems important to systematically include a check for significant weight loss or gain and intensity of physical activity while determining patient history. In addition, it seems relevant to regularly question dysfunctional thoughts related to diet, morphology or ambivalence regarding the desire for a child. These proposals are in line with international recommendations that emphasize the importance of early psychiatric care in order to reduce the risk of post-partum symptoms [5, 16]. It has been described that the symptoms of EDs remain present in pregnant women with an easing of symptoms during the first trimester and a potential upsurge at the end of pregnancy or postpartum [11, 33, 44]. While Yli-Kulha et al. report significantly fewer cases of hospitalization after a pregnancy resulting from fertility treatment, these results should be qualified by the reluctance to consent to hospitalization that separates the mother and child at an early stage.

The strength of our review lies in its methodological quality, which is based on PRISMA criteria. We enabled the identification of a maximum number of articles by using a broad search equation and relatively unrestricted exclusion criteria. The use of several databases also enabled the collection of additional references.

Our study presents several obstacles for the generalizability of the results. Firstly, as described above, the various articles included in the review have inherent methodological limitations with assessment and recruitment biases. The heterogeneity of the results prevents quality meta-analysis from being performed. In addition, the small number of specific studies dealing with the prevalence of EDs in fertility treatment led us to include studies where the raw results allowed us to calculate a prevalence. This choice constitutes a bias, as the prevalence figures calculated do not benefit from statistical analysis assessing the impact of confounding factors.

Conclusion

Our systematic review highlights a very high prevalence of active EDs among infertile women seeking fertility treatment. The prevalence in this population is up to 6 times higher than in regular pregnant women.

Our study describes non-specific or incomplete forms of EDs characterized by cognitive distortions centered on body image and diet, without compensatory behaviors being systematically associated. These forms are less obvious clinically and they are more complex to detect for non-psychiatric health professional. Nevertheless, they present significant obstetrical, neonatal, and psychological morbidities for both mother and child, which justify their early detection. It is therefore a major challenge for fertility professionals to be aware of this condition in order to be able to use specific screening strategies and to offer appropriate care.

Future research remains necessary to develop screening tools for pregnant women in order to gauge more precisely the burden of EDs in this population. Moreover, an assessment of the needs could be of major interest to set up information and prevention campaigns for screening for EDs.

Availability of data and materials

The datasets analysed during the current study are available in the PubMed repository, [https://pubmed.ncbi.nlm.nih.gov], the Cochrane library [https://www.cochranelibrary.com], and Web Of Science [https://www.webofscience.com] or by mailing the corresponding author on reasonable request.

Abbreviations

ED:

Eating disorders

ART:

Assisted reproductive technics

BMI:

Body mass index

EDNOS:

Eating disorder not otherwise specified

BED:

Binge eating disorder

PCOS:

Polycystic ovarian syndrome

References

  1. Galmiche M, Déchelotte P, Lambert G, Tavolacci MP. Prevalence of eating disorders over the 2000–2018 period: a systematic literature review. Am J Clin Nutr. 2019;109(5):1402–13.

    Article  PubMed  Google Scholar 

  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), 2015. Washington: American Psychiatric Association; 2015.

    Google Scholar 

  3. Eik-Nes TT, Horn J, Strohmaier S, Holmen TL, Micali N, Bjørnelv S. Impact of eating disorders on obstetric outcomes in a large clinical sample: a comparison with the HUNT study. Int J Eat Disord. 2018;51(10):1134–43.

    Article  PubMed  Google Scholar 

  4. Arnold C, Johnson H, Mahon C, Agius M. The effect of eating disorders in pregnancy on mother and baby: a review. Psychiatr Danub. 2019;31:4.

    Google Scholar 

  5. Lavie E. recommandation de bonne pratique: boulimie et hyperphagie boulimique. Repérage et éléments généraux de prise en charge. Haute Aut Santé. 2019;333.

  6. Kimmel MC, Ferguson EH, Zerwas S, Bulik CM, Meltzer-Brody S. Obstetric and gynecologic problems associated with eating disorders: obstetric problems associated with eating disorders. Int J Eat Disord. 2016;49(3):260–75.

    Article  CAS  PubMed  Google Scholar 

  7. Kirchengast S, Huber J. Body composition characteristics and fat distribution patterns in young infertile women. Fertil Steril. 2004;81(3):539–44.

    Article  PubMed  Google Scholar 

  8. Bruneau M, Colombel A, Mirallié S, Fréour T, Hardouin J-B, Barrière P, et al. Desire for a child and eating disorders in women seeking infertility treatment. PLoS ONE. 2017;12(6):e0178848.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Boutari C, Pappas PD, Mintziori G, Nigdelis MP, Athanasiadis L, Goulis DG, et al. The effect of underweight on female and male reproduction. Metabolism. 2020;107:154229.

    Article  CAS  PubMed  Google Scholar 

  10. Ålgars M, Huang L, Von Holle AF, Peat CM, Thornton LM, Lichtenstein P, et al. Binge eating and menstrual dysfunction. J Psychosom Res. 2014;76(1):19–22.

    Article  PubMed  Google Scholar 

  11. Easter A, Treasure J, Micali N. Fertility and prenatal attitudes towards pregnancy in women with eating disorders: results from the Avon Longitudinal Study of Parents and Children: Fertility in women with eating disorders. BJOG Int J Obstet Gynaecol. 2011;118(12):1491–8.

    Article  CAS  Google Scholar 

  12. Micali N, dos-Santos-Silva I, De Stavola B, Steenweg-de Graaf J, Jaddoe V, Hofman A, et al. Fertility treatment, twin births, and unplanned pregnancies in women with eating disorders: findings from a population-based birth cohort. BJOG Int J Obstet Gynaecol. 2014;121(4):408–16.

    Article  CAS  Google Scholar 

  13. Paslakis G, Zwaan M. Clinical management of females seeking fertility treatment and of pregnant females with eating disorders. Eur Eat Disord Rev mai. 2019;27(3):215–23.

    Article  Google Scholar 

  14. Busson J. Les sages-femmes face aux troubles du comportement alimentaire: quelles connaissances? Quel dépistage? Gynécologie Obstétrique. 2014;62:52.

    Google Scholar 

  15. Bye A, Shawe J, Bick D, Easter A, Kash-Macdonald M, Micali N. Barriers to identifying eating disorders in pregnancy and in the postnatal period: a qualitative approach. BMC Pregnan Childbirth. 2018;18(1):114.

    Article  Google Scholar 

  16. NICE guideline. Eating disorders: recognition and treatment. Eat Disord. 2017;42:84.

    Google Scholar 

  17. Gedda M. Traduction française des lignes directrices PRISMA pour l’écriture et la lecture des revues systématiques et des méta-analyses. Kinésithérapie Rev. 2015;15(157):39–44.

    Article  Google Scholar 

  18. Abraham S, Mira M, Llewellyn-Jones D. Should ovulation be induced in women recovering from an eating disorder or who are compulsive exercisers? Fertil Steril. 1990;53(3):566–8.

    Article  CAS  PubMed  Google Scholar 

  19. Cousins A, Freizinger M, Duffy ME, Gregas M, Wolfe BE. Self-report of eating disorder symptoms among women with and without infertility. J Obstet Gynecol Neonatal Nurs. 2015;44(3):380–8.

    Article  PubMed  Google Scholar 

  20. Langley S. A nutrition screening form for female infertility patients. Can J Diet Pract Res. 2014;75(4):195–201.

    Article  PubMed  Google Scholar 

  21. Rodino IS, Byrne S, Sanders KA. Disordered eating attitudes and exercise in women undergoing fertility treatment. Aust N Z J Obstet Gynaecol. 2016;56(1):82–7.

    Article  PubMed  Google Scholar 

  22. Sbaragli C, Morgante G, Goracci A, Hofkens T, De Leo V, Castrogiovanni P. Infertility and psychiatric morbidity. Fertil Steril. 2008;90(6):2107–11.

    Article  PubMed  Google Scholar 

  23. Resch M, Nagy GY, Pintear J, Szendei GY, Haaasz P. Eating disorders and depression in hungarian women with menstrual disorders and infertility. J Psychosom Obstet Gynecol. 1999;20(3):152–7.

    Article  CAS  Google Scholar 

  24. Rodino IS, Byrne S, Sanders KA. Obesity and psychological wellbeing in patients undergoing fertility treatment. Reprod Biomed Online. 2016;32(1):104–12.

    Article  PubMed  Google Scholar 

  25. Stewart DE, Erlick Robinson G, Goldbloom DS, Wright C. Infertility and eating disorders. Am J Obstet Gynecol. 1990;163(4):1196–9.

    Article  CAS  PubMed  Google Scholar 

  26. Volgsten H, Skoog Svanberg A, Ekselius L, Lundkvist O, Sundstrom PI. Prevalence of psychiatric disorders in infertile women and men undergoing in vitro fertilization treatment. Hum Reprod. 2008;23(9):2056–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Yli-Kuha A-N, Gissler M, Klemetti R, Luoto R, Koivisto E, Hemminki E. Psychiatric disorders leading to hospitalization before and after infertility treatments. Hum Reprod. 2010;25(8):2018–23.

    Article  PubMed  Google Scholar 

  28. Christin-Maitre S, de Crécy M. Grossesses obtenues par administration pulsatile de GnRH: résultats d’une large étude rétrospective multicentrique. J Gynécologie Obstétrique Biol Reprod. 2007;36(1):8–12.

    Article  CAS  Google Scholar 

  29. Barbosa-Magalhaes I, Corcos M, Galey J, Perdigao-Cotta S, Papastathi C, de Crecy M, et al. Prevalence of lifetime eating disorders in infertile women seeking pregnancy with pulsatile gonadotropin-releasing hormone therapy. Eat Weight Disord. 2020;26(2):709–15.

    Article  PubMed  Google Scholar 

  30. Freizinger M, Franko DL, Dacey M, Okun B, Domar AD. The prevalence of eating disorders in infertile women. Fertil Steril. 2010;93(1):72–8.

    Article  PubMed  Google Scholar 

  31. Assens M, Ebdrup NH, Pinborg A, Schmidt L, Hougaard CO, Hageman I. Assisted reproductive technology treatment in women with severe eating disorders: a national cohort study. Acta Obstet Gynecol Scand. 2015;94(11):1254–61.

    Article  PubMed  Google Scholar 

  32. Tranoulis A, Laios A, Pampanos A, Yannoukakos D, Loutradis D, Michala L. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis. Fertil Steril. 2018;109(4):708-719.e8.

    Article  CAS  PubMed  Google Scholar 

  33. Thompson K. An application of psychosocial frameworks for eating disorder risk during the postpartum period: a review and future directions. Arch Womens Ment Health. 2020;23(5):625–33.

    Article  PubMed  Google Scholar 

  34. Martínez-Olcina M, Rubio-Arias JA, Reche-García C, Leyva-Vela B, Hernández-García M, Hernández-Morante JJ, et al. Eating disorders in pregnant and breastfeeding women: a systematic review. Medicina (Mex). 2020;56(7):352.

    Article  Google Scholar 

  35. Soares RM, Nunes MA, Schmidt MI, Giacomello A, Manzolli P, Camey S, et al. Inappropriate eating behaviors during pregnancy: prevalence and associated factors among pregnant women attending primary care in southern Brazil. Int J Eat Disord. 2009;42(5):387–93.

    Article  PubMed  Google Scholar 

  36. Watson HJ, O’Brien A, Sadeh-Sharvit S. Children of parents with eating disorders. Curr Psychiatry Rep. 2018;20(11):101.

    Article  PubMed  Google Scholar 

  37. Fassino S, Garzaro L, Pierò A, Daga GA, Bulik C. Eating behaviors and attitudes in women with infertility: a controlled study: eating attitudes and behaviors in infertility. Int J Eat Disord. 2003;33(2):178–84.

    Article  PubMed  Google Scholar 

  38. Makino M, Yasushi M, Tsutsui S. The risk of eating disorder relapse during pregnancy and after delivery and postpartum depression among women recovered from eating disorders. BMC Pregn Childbirth. 2020;20(1):323.

    Article  Google Scholar 

  39. Barona M, Taborelli E, Corfield F, Pawlby S, Easter A, Schmidt U, et al. Neurobehavioural and cognitive development in infants born to mothers with eating disorders. J Child Psychol Psychiatry. 2017;58(8):931–8.

    Article  PubMed  Google Scholar 

  40. Rodino IS, Byrne SM, Sanders KA. Eating disorders in the context of preconception care: fertility specialists’ knowledge, attitudes, and clinical practices. Fertil Steril. 2017;107(2):494–501.

    Article  PubMed  Google Scholar 

  41. Ebneter DS, Latner JD. Stigmatizing attitudes differ across mental health disorders: a comparison of stigma across eating disorders, obesity, and major depressive disorder. J Nerv Ment Dis. 2013;201(4):281–5.

    Article  PubMed  Google Scholar 

  42. Andersen AE, Ryan GL. Eating disorders in the obstetric and gynecologic patient population. Obstet Gynecol. 2009;114(6):1353–67.

    Article  CAS  PubMed  Google Scholar 

  43. Kutz AM, Marsh AG, Gunderson CG, Maguen S, Masheb RM. Eating disorder screening: a systematic review and meta-analysis of diagnostic test characteristics of the SCOFF. J Gen Intern Med. 2020;35(3):885–93.

    Article  PubMed  Google Scholar 

  44. Sebastiani G, Andreu-Fernández V, Herranz Barbero A, Aldecoa-Bilbao V, Miracle X, Meler Barrabes E, et al. Eating disorders during gestation: implications for mother’s health, fetal outcomes, and epigenetic changes. Front Pediatr. 2020;8:587.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

Design of the study: MLF, ER. Data analysis: MLF, AC, ER. Article writing and revising: MLF, ER, AC. Revision of the manuscript: ER, GL, AP, PD. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Marine Le Floch.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Le Floch, M., Crohin, A., Duverger, P. et al. Prevalence and phenotype of eating disorders in assisted reproduction: a systematic review. Reprod Health 19, 38 (2022). https://doi.org/10.1186/s12978-022-01341-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12978-022-01341-w

Keywords